The US is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults.
Novavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S. (...)
A U.S. advisory panel voted 14-10 that Pfizer Inc.'s pain reliever Bextra should stay on the market, an agency spokeswoman said.
Eight members of the Food and Drug Administration advisory committee abstained from voting, the spokeswoman said. --SP (...)
